ES2126474A1 - Procedimiento para la preparacion de composiciones orales que contienn quinolonas - Google Patents

Procedimiento para la preparacion de composiciones orales que contienn quinolonas

Info

Publication number
ES2126474A1
ES2126474A1 ES09550022A ES9550022A ES2126474A1 ES 2126474 A1 ES2126474 A1 ES 2126474A1 ES 09550022 A ES09550022 A ES 09550022A ES 9550022 A ES9550022 A ES 9550022A ES 2126474 A1 ES2126474 A1 ES 2126474A1
Authority
ES
Spain
Prior art keywords
preparation
quinolone
oral compositions
containing oral
quinolones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09550022A
Other languages
English (en)
Other versions
ES2126474B1 (es
Inventor
Gabriel Gousset
Philippe Riviere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone DPC Europe
Original Assignee
Rhone DPC Europe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone DPC Europe filed Critical Rhone DPC Europe
Publication of ES2126474A1 publication Critical patent/ES2126474A1/es
Application granted granted Critical
Publication of ES2126474B1 publication Critical patent/ES2126474B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE COMPOSICIONES ORALES QUE CONTIENEN QUINOLONAS, CARACTERIZADO PORQUE SE INTRODUCE UNA ETAPA DE COMPACTACION DESPUES DE LA MOLIENDA O TRITURACION, PREVIO A LA COMPRESION DE LA MEZCLA DEL PRINCIPIO ACTIVO Y LOS EXCIPIENTES.
ES009550022A 1993-10-21 1994-10-19 Procedimiento para la preparacion de composiciones orales que contienn quinolonas Expired - Lifetime ES2126474B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9312550A FR2711524B1 (fr) 1993-10-21 1993-10-21 Procédé de préparation de compositions orales contenant des quinolones.

Publications (2)

Publication Number Publication Date
ES2126474A1 true ES2126474A1 (es) 1999-03-16
ES2126474B1 ES2126474B1 (es) 1999-11-16

Family

ID=9452072

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009550022A Expired - Lifetime ES2126474B1 (es) 1993-10-21 1994-10-19 Procedimiento para la preparacion de composiciones orales que contienn quinolonas

Country Status (29)

Country Link
US (1) US5840333A (es)
EP (1) EP0724442A1 (es)
AT (1) ATA905894A (es)
AU (1) AU7997094A (es)
BE (1) BE1007326A3 (es)
CA (1) CA2174444A1 (es)
CH (1) CH686555A5 (es)
CO (1) CO4180603A1 (es)
CZ (1) CZ113696A3 (es)
DZ (1) DZ1818A1 (es)
EE (1) EE9600050A (es)
ES (1) ES2126474B1 (es)
FI (1) FI961717A0 (es)
FR (1) FR2711524B1 (es)
GB (1) GB2297908B (es)
GR (1) GR1002181B (es)
HU (1) HUT74181A (es)
IE (1) IE940838A1 (es)
IT (1) IT1270672B (es)
MA (1) MA23331A1 (es)
NO (1) NO961429L (es)
NZ (1) NZ274874A (es)
OA (1) OA10282A (es)
PL (1) PL314005A1 (es)
SG (1) SG52202A1 (es)
SK (1) SK50596A3 (es)
TN (1) TNSN94110A1 (es)
WO (2) WO1995011023A1 (es)
ZA (1) ZA948175B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177101B1 (en) * 1998-06-11 2001-01-23 Pharmacia & Upjohn Company Delavirdine high strength tablet formulation
US6342598B1 (en) 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
CN102499928A (zh) 2004-08-13 2012-06-20 先灵-普劳有限公司 包含抗菌素、三唑和皮质类固醇的药物制剂

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0189114A2 (en) * 1985-01-22 1986-07-30 Merck & Co. Inc. Quinoline carboxylic acid tablet and formulation
JPH01175936A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd ６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤
WO1991000085A1 (en) * 1989-06-26 1991-01-10 Warner-Lambert Company Sustained release pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10175936A (ja) * 1996-12-17 1998-06-30 Kao Corp 新規アミドアミノポリカルボン酸又はその塩、及びそれを含有する洗浄剤組成物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0189114A2 (en) * 1985-01-22 1986-07-30 Merck & Co. Inc. Quinoline carboxylic acid tablet and formulation
JPH01175936A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd ６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤
WO1991000085A1 (en) * 1989-06-26 1991-01-10 Warner-Lambert Company Sustained release pharmaceutical compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BASE DE DATOS WPI en EPOQUE, European Patent Office, Rijswijk (Paises Bajos) & JP 1175936 A (KYORIN) *

Also Published As

Publication number Publication date
OA10282A (fr) 1997-10-07
GB9608316D0 (en) 1996-06-26
WO1995011023A1 (fr) 1995-04-27
HUT74181A (en) 1996-11-28
ZA948175B (en) 1995-06-08
NZ274874A (en) 1997-10-24
GB2297908B (en) 1997-12-10
US5840333A (en) 1998-11-24
FI961717A (fi) 1996-04-19
ES2126474B1 (es) 1999-11-16
FI961717A0 (fi) 1996-04-19
DZ1818A1 (fr) 2002-02-17
EP0724442A1 (fr) 1996-08-07
FR2711524B1 (fr) 1995-11-24
CZ113696A3 (en) 1996-07-17
GB2297908A (en) 1996-08-21
SK50596A3 (en) 1997-02-05
FR2711524A1 (fr) 1995-05-05
CO4180603A1 (es) 1995-06-07
EE9600050A (et) 1996-10-15
BE1007326A3 (fr) 1995-05-16
MA23331A1 (fr) 1995-04-01
IE940838A1 (en) 1995-05-03
NO961429D0 (no) 1996-04-11
AU7997094A (en) 1995-05-08
HU9601041D0 (en) 1996-06-28
SG52202A1 (en) 1998-09-28
CA2174444A1 (fr) 1995-04-27
GR1002181B (en) 1996-03-12
ITMI942130A0 (it) 1994-10-19
IT1270672B (it) 1997-05-07
NO961429L (no) 1996-04-11
CH686555A5 (fr) 1996-04-30
ITMI942130A1 (it) 1996-04-19
PL314005A1 (en) 1996-08-05
TNSN94110A1 (fr) 1995-09-21
ATA905894A (de) 2000-06-15
WO1995011022A1 (fr) 1995-04-27

Similar Documents

Publication Publication Date Title
BG102254A (en) Oral fast soluble compositions as dopamine antagonists
AU1537095A (en) Therapeutic agents containing thyroid hormones
MY115339A (en) Compositions containing micronized nebivolol
ATE427925T1 (de) Phenoxycarbonsaureverbindungen und zusammensetzungen zur verabreichung aktiver wirkstoffe
NZ333385A (en) Solid oral dosage forms containing 35% of valsartan
AU2001241631A1 (en) Compositions suitable for oral administration and kits and methods thereof for hydrating mammalian skin
EP0151344A3 (en) A chewing gum composition, a process for preparing a chewing gum tablet therefrom, and a chewing gum tablet
NZ318282A (en) Pharmaceutical formulation containing amoxycillin and clavulanate in a weight ratio of 12:1 and 20:1
BG103000A (en) Compositions for single daily dosage in the treatment of cyclooxygenase-2-dependent diseases
AU2002231654A1 (en) Pharmaceutical paste comprising an acid-labile active ingredient
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
EA200400731A1 (ru) Способ и фармацевтическая композиция для непредвиденной контрацепции
EE03089B1 (et) Ibuprofeeni sisaldav kihisev ravimpreparaat ja selle valmistamise meetod
NZ510583A (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
IE800406L (en) Pharmaceutical composition
HUP9700826A1 (hu) Peptikus fekély elleni gyógyászati készítmények
GB9424766D0 (en) Pharmaceutical composition
PH31320A (en) Fenbendazole formulations.
CA2063273A1 (en) Surfactant compositions and methods
ES2126474A1 (es) Procedimiento para la preparacion de composiciones orales que contienn quinolonas
AU3777197A (en) Cyclosporin formulation
UA74388C2 (uk) Фармацевтичні композиції тизоксаніду і нітазоксаніду
AU5493298A (en) Stabilized pharmaceutical compositions and process for the preparation thereof
ES8608516A1 (es) Procedimiento para la preparacion de acidos 4-isoxazolil- tiazol-2-oxamicos y sus derivados

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990316

Kind code of ref document: A1

Effective date: 19990316

FA2A Application withdrawn

Effective date: 20000809